[go: up one dir, main page]

BR9801044A - Composições antiácidas lìquidas. - Google Patents

Composições antiácidas lìquidas.

Info

Publication number
BR9801044A
BR9801044A BR9801044-1A BR9801044A BR9801044A BR 9801044 A BR9801044 A BR 9801044A BR 9801044 A BR9801044 A BR 9801044A BR 9801044 A BR9801044 A BR 9801044A
Authority
BR
Brazil
Prior art keywords
liquid
liquid antacid
antacid compositions
antacid
compositions
Prior art date
Application number
BR9801044-1A
Other languages
English (en)
Other versions
BR9801044B1 (pt
Inventor
John J Dubek
Gerard P Mcnally
Bruce P Smith
Original Assignee
Johnson & Johndon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johndon filed Critical Johnson & Johndon
Publication of BR9801044A publication Critical patent/BR9801044A/pt
Publication of BR9801044B1 publication Critical patent/BR9801044B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)

Abstract

Patente de Invenção: <B>"COMPOSIçõES ANTIáCIDAS LìQUIDAS"<D>. Composições antiácidas líquidas de carbonato de cálcio contendo um ou mais agentes de ajuste de pH para manter o pH acima de 9,0, preferivelmente acima de 9,5. O líquido antiácido resultante possui resistência superior a ataque microbiano e propriedades de sabor melhoradas.
BRPI9801044-1A 1997-04-16 1998-04-14 preparação antiácida lìquida. BR9801044B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/838,239 US5914135A (en) 1997-04-16 1997-04-16 Liquid antacid compositions

Publications (2)

Publication Number Publication Date
BR9801044A true BR9801044A (pt) 2000-01-11
BR9801044B1 BR9801044B1 (pt) 2009-05-05

Family

ID=25276618

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9801044-1A BR9801044B1 (pt) 1997-04-16 1998-04-14 preparação antiácida lìquida.

Country Status (18)

Country Link
US (1) US5914135A (pt)
EP (1) EP0872241B1 (pt)
JP (1) JPH10316577A (pt)
KR (1) KR100588245B1 (pt)
CN (1) CN1174754C (pt)
AR (1) AR012438A1 (pt)
AT (1) ATE232105T1 (pt)
AU (1) AU727008B2 (pt)
BR (1) BR9801044B1 (pt)
CZ (1) CZ292399B6 (pt)
DE (1) DE69811137T2 (pt)
DK (1) DK0872241T3 (pt)
ES (1) ES2191254T3 (pt)
HU (1) HU224195B1 (pt)
NZ (1) NZ330173A (pt)
PL (1) PL189771B1 (pt)
RU (1) RU2193889C2 (pt)
ZA (1) ZA983167B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
US6048552A (en) * 1997-03-26 2000-04-11 Chattem Chemicals, Inc. DASC compositions, process for preparing same and suspensions containing same
US5914135A (en) * 1997-04-16 1999-06-22 Mcneil-Ppc, Inc. Liquid antacid compositions
AU4759099A (en) * 1998-09-21 2000-03-23 Mcneil-Ppc, Inc. Heat stable antacid and antigas suspensions
AU2004201831B2 (en) * 1998-09-21 2006-11-02 Mcneil-Ppc, Inc. Heat stable antacid and antigas suspensions
US6887926B1 (en) 2001-11-16 2005-05-03 Oatey Co. Bonding compositions for chlorinated polymers and methods of using the same
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
US7473684B2 (en) * 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
WO2007031785A2 (en) 2005-09-16 2007-03-22 Selamine Ltd Bisphosphonate formulation
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
DE102008019339A1 (de) * 2008-04-16 2009-10-22 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die medizinische Anwendung, insbesondere Antazidum
EP2354191B1 (en) * 2010-01-25 2013-04-03 Omya Development AG Use of 2-((1-methylpropyl)amino)ethanol as additive in aqueous suspensions of calcium carbonate-comprising materials
ES2411109T3 (es) * 2010-06-07 2013-07-04 Omya Development Ag Uso de 2-aminoetanol como aditivo en suspensiones acuosas de materiales que comprenden carbonato cálcico
BR112014026407B1 (pt) * 2012-04-23 2020-12-22 Bharat Biotech International Limited formulação de vacina líquida
US20160346342A1 (en) 2015-05-29 2016-12-01 Johnson & Johnson Consumer Inc. Use of organic citrus extract with high antimicrobial capacity as a preservative system in liquids, emulsions, suspensions, creams and antacids
RU2715906C2 (ru) 2015-05-29 2020-03-04 Джонсон энд Джонсон Консьюмер Инк. Применение органического экстракта цитрусовых с высокой противомикробной активностью и ксилита в качестве системы консервантов в жидкостях, эмульсиях, суспензиях, кремах и антацидах
KR101841355B1 (ko) * 2016-09-02 2018-03-22 영남대학교 산학협력단 D-싸이클로세린의 약제학적 제형 및 이의 제조방법
CN108721213A (zh) * 2017-04-13 2018-11-02 辽宁大熊制药有限公司 铝镁混悬液及其制备方法
KR101926853B1 (ko) * 2018-04-13 2018-12-07 보령제약 주식회사 약학적 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US920792A (en) * 1908-01-02 1909-05-04 Julius Uherkovich De Uherkocz Winged propelling and guiding mechanism for air-ships.
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
DE69414845T2 (de) * 1993-05-26 1999-07-08 The Procter & Gamble Co., Cincinnati, Ohio Flüssigantazidzusammensetzungen
US5496567A (en) * 1993-08-26 1996-03-05 Mclean; Linsey Composition having buffering and nutritional properties
NZ275690A (en) * 1993-10-13 1998-08-26 Warner Lambert Co Antacid composition comprising calcium carbonate and a second buffer compound which is calcium citrate and/or calcium phosphate
US5455050A (en) * 1993-11-12 1995-10-03 Mcneil-Ppc, Inc. Aqueous antacids with calcium carbonate and magnesium salt
US5498426A (en) * 1994-10-03 1996-03-12 The Procter & Gamble Company Liquid antacid compositions
DE19529862A1 (de) * 1995-08-14 1997-02-20 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
US5914135A (en) * 1997-04-16 1999-06-22 Mcneil-Ppc, Inc. Liquid antacid compositions

Also Published As

Publication number Publication date
JPH10316577A (ja) 1998-12-02
AR012438A1 (es) 2000-10-18
EP0872241A3 (en) 1999-09-22
RU2193889C2 (ru) 2002-12-10
EP0872241A2 (en) 1998-10-21
AU727008B2 (en) 2000-11-30
ZA983167B (en) 1999-10-15
CZ292399B6 (cs) 2003-09-17
EP0872241B1 (en) 2003-02-05
BR9801044B1 (pt) 2009-05-05
HU224195B1 (hu) 2005-06-28
US5914135A (en) 1999-06-22
DE69811137D1 (de) 2003-03-13
ES2191254T3 (es) 2003-09-01
CN1203079A (zh) 1998-12-30
DK0872241T3 (da) 2003-04-28
HUP9800876A2 (hu) 1999-05-28
HUP9800876A3 (en) 2000-07-28
PL325821A1 (en) 1998-10-26
KR100588245B1 (ko) 2006-09-20
ATE232105T1 (de) 2003-02-15
DE69811137T2 (de) 2003-11-27
CN1174754C (zh) 2004-11-10
CZ113498A3 (cs) 1998-11-11
PL189771B1 (pl) 2005-09-30
NZ330173A (en) 1998-11-25
KR19980081452A (ko) 1998-11-25
HU9800876D0 (en) 1998-05-28
AU6190298A (en) 1998-10-22

Similar Documents

Publication Publication Date Title
BR9801044A (pt) Composições antiácidas lìquidas.
FR2774385B1 (fr) Compositions liquides viscosifiantes ou gelifiantes de facon reversible sous l&#39;effet de cisaillement
BR9915001A (pt) Composição herbicida
MY118538A (en) Polymeric compositions and their production and uses
DE69928938D1 (de) Neues cyclosporin mit verbesserter wirkung
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
IL129592A0 (en) 5-HT1f agonists
BR0116831A (pt) Composição oral e seu uso
BR9917441A (pt) Métodos para a preparação de composições de nanocompósito de poliamida por polimerização in situ
DE69905170T2 (de) Thiazolopyrimidinderivate
NO20005668D0 (no) Forbindelser med veksthormonfrigjörende egenskaper
BG104916A (en) Calcilytic compounds
ATE262277T1 (de) Wasser-dispergierbare agrochemische zusammensetzungen
DE69900080D1 (de) Wasser-in-Öl Zusammensetzung mit verlaufsveränderlicher Schergeschwindigkeit
YU13301A (sh) Muskarinski agonisti i antagonisti
NO20005883L (no) Anvendelse av &lt;alfa&gt;1&lt;beta&gt;1-integrinreseptorinhibitorer og TGF-&lt;beta&gt;1-inhibitorer i behandling av nyresykdom
AU1667500A (en) N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthal necarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists
DE59909717D1 (de) Verfahren zur Herstellung von festen Dosierungsformen
BR0008445A (pt) Emulsões pit
NZ521453A (en) Clay-containing mixture or blend capable of forming a moisture resistant gel, and use of that mixture and blend
BR9711273A (pt) 1,2,3,4- Tetraidro-2-dibenzofuranaminas substituidas e 2- aminociclohepta b benzofuranos
WO2003048342A3 (en) Liquid yeast compositions
NO20006699D0 (no) Forbindelser med veksthormonfrigjörende egenskaper
BR0113070A (pt) Composições farmacêuticas contendo carbonato de lìtio
FR2718923B1 (fr) Composition désinfectante en solution aqueuse renfermant de l&#39;orthophtalaldéhyde.

Legal Events

Date Code Title Description
HHB Publication of an application: rectification
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 28/07/2009, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 18A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.